The Basic Principles Of Adavosertib
Use of solid CYP1A2 inhibitors must be discontinued before initiating pirfenidone and prevented in the course of therapy; if powerful CYP1A2 inhibitors are the only drug of decision, dosage reductions are encouragedUse of sturdy CYP1A2 inhibitors must be discontinued right before initiating therapy and avoided during therapy; if solid CYP1A2 inhibi